Back to search

Article

The utility of sputum supernatant as an alternative liquid biopsy specimen for next-generation sequencing-based genomic profiling

2020-11-20

Abstract excerpt

<title>Abstract</title> <p>Background Comprehensive mutation profiling has become a standard clinical practice in the management of advanced lung cancer. In addition to tissue and plasma, other body fluids are also being actively explored as alternative sources of tumor DNA. In this study, we investigated the potential of induced sputum obtained from patients with non-small cell lung cancer (NSCLC) for mutation...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
56a6086b-b324-5211-9a7d-ed87afd1232f
DOI
10.21203/rs.3.rs-108555/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The utility of sputum supernatant as an alternative liquid biopsy specimen for next-generation sequencing-based genomic profilingDOI 10.21203/rs.3.rs-108555/v1
The utility of sputum supernatant as an alternative liquid biopsy specimen for next-generation sequencing-based somatic variation profilingSemantic proximity
Comprehensive characterization reveals sputum supernatant as a valuable alternative liquid biopsy for genome profiling in advanced non-small cell lung cancerSemantic proximity
Differences in the genomic profiles of cell‐free DNA between plasma, sputum, urine, and tumor tissue in advanced NSCLCSemantic proximity
Malignant pleural effusion supernatant is an alternative liquid biopsy specimen for comprehensive mutational profilingSemantic proximity
Detection of EGFR gene mutation status from pleural effusions and other body fluid specimens in patients with lung adenocarcinomaSemantic proximity
Study on NGS-based molecular profiling of malignant pleural effusion supernatant cfDNA in guiding targeted therapy for non-small cell lung cancer.Semantic proximity
Feasibility of Bronchial Washing Fluid-Based Approach to Early-Stage Lung Cancer DiagnosisSemantic proximity
Tumor-derived DNA from pleural effusion supernatant as a promising alternative to tumor tissue in genomic profiling of advanced lung cancerSemantic proximity
Sputum cell-free DNA for detection of alterations of multiple driver genes in lung adenocarcinoma.Semantic proximity
Sputum cell-free DNA: Valued surrogate sample for the detection of EGFR exon 20 p.T790M mutation in patients with advanced lung adenocarcinoma and acquired resistance to EGFR-TKIs.Semantic proximity
The Emerging Role of "Liquid Biopsies," Circulating Tumor Cells, and Circulating Cell-Free Tumor DNA in Lung Cancer Diagnosis and Identification of Resistance Mutations.Semantic proximity
Detection and comparison of EGFR mutations from supernatants that contain cell-free DNA and cell pellets from FNA non-small cell lung cancer specimens.Semantic proximity
Select a neighboring publication to make it the new centre.